ClinicalTrialsFinder
RecruitingNCT07352514

Use of PEA and Scutellaria in Synergy With Therapeutic Exercise in Chemotherapy-induced Peripheral Neuropathy (CIPN): a Clinical Trial

Sponsor

University of Palermo

Enrollment

40 participants

Start Date

Mar 15, 2025

Study Type

OBSERVATIONAL

Conditions

Chemotherapy-induced Peripheral Neuropathy (CIPN)Neuropathic Pain

Summary

This study aims to find out if taking specific dietary supplements (PEA and Scutellaria) along with therapeutic exercise can help reduce nerve pain and damage caused by chemotherapy. Many cancer patients experience nerve-related side effects from chemotherapy, which can significantly impact their quality of life. The study will observe patients who use these supplements and exercises to see if they can effectively manage and improve their nerve health and reduce pain.

Eligibility

Min Age: 18 Years

Inclusion Criteria6

  • Adults aged 18 years and older.
  • Patients who have undergone chemotherapy treatment within the previous 6 months.
  • Patients treated with PEA, Scutellaria, and standardized therapeutic exercise according to the EXCAP protocol from April 2025 to September 2025.
  • Patients with a washout period from opioid-based analgesic therapy of at least 10 days or who are not receiving opioid-based analgesic therapy.
  • Patients presenting with neuropathic pain (NRS ≥ 5).
  • Patients able to provide written informed consent.

Exclusion Criteria5

  • Patients younger than 18 years.
  • Patients with hypersensitivity to PEA or any of the excipients listed in the Summary of Product Characteristics (SPC).
  • Patients with diabetic pathology.
  • Patients with severe hepatic impairment.
  • Patients with severe disabilities that compromise the execution of therapeutic exercise.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

A.O.U.P. P. Giaccone, Palermo, Italia 90127

Palermo, Italia, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07352514

Related Trials

Pain Outcomes After Digital Amputation Using Tulavi Allay™ Nerve Cap

NCT069156621 location

Neuropathic Characteristics of Subacromial Pain Syndrome

NCT070571281 location

Virtual Reality (VR) Self-Hypnosis Software

NCT063988471 location

Chronic Unilateral Lumbar Radicular Pain

NCT060927491 location

Deep rTMS (H-coil) for Neuropathic Pain or Fibromyalgia

NCT062504912 locations